An Alternative Approach to Assess Exchangeability of a Test Treatment and the Standard Treatment with Normally Distributed ResponseFootnote∗
∗This paper does not represent the official position of U.S. Food and Drug Administration.

Yi Tsong Division of Biometric VI, OB, CDER, FDA, Silver Spring, Maryland, USACorrespondence[email protected]

Meiyu Shen Division of Biometric VI, OB, CDER, FDA, Silver Spring, Maryland, USA

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Xiaoyu Dong & Yi Tsong. (2014) Equivalence Assessment for Interchangeability Based on Two-Sided Tests. Journal of Biopharmaceutical Statistics 24:6, pages 1312-1331.
Read now

Xiaoyu Dong, Yi Tsong & Meiyu Shen. (2014) Equivalence Tests for Interchangeability Based on Two One-Sided Probabilities. Journal of Biopharmaceutical Statistics 24:6, pages 1332-1348.
Read now

Yi Tsong, Roswitha Kelly, Meiyu Shen & Jinglin Zhong. (2009) Discussion. Journal of Quality Technology 41:2, pages 142-144.
Read now

Jinglin Zhong, Kathy Lee & Yi Tsong. (2008) Statistical Assessment of Analytical Method Transfer∗ . Journal of Biopharmaceutical Statistics 18:5, pages 1005-1012.
Read now

Articles from other publishers (3)

Gwowen Shieh. (2022) Assessing individual equivalence in parallel group and crossover designs: Exact test and sample size procedures. PLOS ONE 17:5, pages e0269128.
Crossref

Shein-Chung Chow. 2011. Controversial Statistical Issues in Clinical Trials. Controversial Statistical Issues in Clinical Trials 553 576 .

Hon-Yi Shi, Hao-Hsien Lee, Chong-Chi Chiu, Herng-Chia Chiu, Yih-Huei Uen & King-Teh Lee. (2008) Responsiveness and Minimal Clinically Important Differences after Cholecystectomy: GIQLI Versus SF-36. Journal of Gastrointestinal Surgery 12:7, pages 1275-1282.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

An Alternative Approach to Assess Exchangeability of a Test Treatment and the Standard Treatment with Normally Distributed ResponseFootnote∗
∗This paper does not represent the official position of U.S. Food and Drug Administration.

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An Alternative Approach to Assess Exchangeability of a Test Treatment and the Standard Treatment with Normally Distributed ResponseFootnote∗∗This paper does not represent the official position of U.S. Food and Drug Administration.

Citations (7)

Read on this site (4)

Articles from other publishers (3)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

An Alternative Approach to Assess Exchangeability of a Test Treatment and the Standard Treatment with Normally Distributed ResponseFootnote∗
∗This paper does not represent the official position of U.S. Food and Drug Administration.